Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Amgen

Dow Jones Rises After Jobs Report; Carl Icahn Stock Crashes 30% On Dividend Cut

The Dow Jones Industrial Average rose 190 points Friday after the July jobs report. Amazon surged on strong earnings, while Apple stock sold off. Icahn Enterprises crashed.

Investors Business Daily

Amgen Is 'Confident' It Can Wrap The Horizon Takeover By December

Amgen stock jumped Friday after topping Wall Street's second-quarter views, but investors remain zeroed in on the takeover of Horizon.

Investors Business Daily

The Blazing Weight-Loss Drug Battle: Can Anyone Unseat Undisputed Leaders Novo Nordisk And Lilly?

An overweight world is hungry for obesity treatments, driving big forecasts for weight loss drugs. For now, two pharmaceutical stocks own the market.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Cheaper competition for Humira is hitting the market, but savings will depend on your insurance

Patients who take the autoimmune disease treatment Humira may see some price relief when several lower-cost, biosimilar versions of the AbbVie drug reach the U.S. market in July

The Independent UK

The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree

Big Pharma has a problem, and buying up biotech companies helps solve it. But the FTC has its own ideas about industry mergers. Here's where things stand.

Investors Business Daily

Jailed Dutch-Chinese scientist 'forgotten' by his country and company

Dr Zhang Mingqiang is in cell number 204 of Shanghai’s notorious Qingpu prison – sentenced to six years for spying. He worked for US pharmaceutical giant Amgen in charge of research and development at their Asian operations. Caught in the crossfire between Beijing, the US and the EU, Zhang and…

Radio France Internationale

A more aggressive FTC is starting to target drug mergers and industry middlemen

Under the leadership of an aggressive opponent of anti-competitive business practices, the Federal Trade Commission is moving against drug companies and industry middlemen as part of the Biden administration’s push for lower drug prices at the pharmacy counter.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Stock Market Rally Hits 2023 Highs As Big Techs Lead; Tesla, Walmart, On Holding In Focus: Weekly Review

The Nasdaq and S&P 500 hit 2023 highs, fueled by AI-led chips and software names. But market leadership remains narrow.

Investors Business Daily

Stocks Undercut as Little Progress is seen in U.S. Debt Ceiling Talks

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.63%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.01%, and the Nasdaq 100 Index ($IU ) (QQQ ) closed up +0.09%. Stock indexes Tuesday settled mixed, with the Dow Jones...

Barchart

US sues to block $28 bn Amgen biopharma acquisition

New York (AFP) - US regulators filed a lawsuit Tuesday to block biopharmaceutical firm Amgen's proposed $28 billion takeover of drug maker Horizon Therapeutics, saying the transaction would harm consumers.

AFP

Monopoly concerns push FTC to sue to block Amgen's more than $26B deal for Horizon

Federal regulators are suing to block biotech drug developer Amgen’s more than $26 billion deal for Horizon Therapeutics

The Independent UK

Stocks Mixed as Debt Ceiling Talks Resume

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.16%. U.S. stocks this morning are mixed, with the Dow...

Barchart

Stock Market Mixed Ahead Of Debt Ceiling Talks. Advanced Micro Devices Hits Buy Point.

Advanced Micro Devices rallied over 5% on hedge fund news.

Investors Business Daily

Horizon Tumbles — Taking Seagen, Prometheus With It — As FTC Blocks Amgen Takeover

The FTC plans to block Amgen's takeover of Horizon. The move reverberated across biotechs, with an HZNP stock crash leading the way.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Markets Today: Stocks Slip Ahead of U.S. Debt Ceiling Talks

Morning Markets June E-Mini S&P 500 futures (ESM2 3) this morning are down -0.26%, and June Nasdaq 100 E-Mini futures (NQM2 3) are down -0.21%. U.S. stock index futures this morning are moderately lower as the markets await any new developments on the debt ceiling stalemate. President Biden will meet...

The Street

Stocks Slip Lower, Retail Sales On Deck, Home Depot Earnings, Buffett Adds Capital One, Horizon Therapeutics Deal In Doubt - 5 Things To Know

Stock futures slip lower with debt ceiling talks in focus; Retail sales on deck after consumers powered Q1 GDP growth; Home Depot earnings in focus as retail week heats up; Warren Buffett's Berkshire Hathaway takes new position in Capital One and Horizon Therapeutics plunges on report FTC will sue to…

Tribune News Service

The drug company that prospered without creating any drugs

The new drug looked so promising — except for that one warning sign.

Fortune

How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own

Horizon grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Red-Hot Obesity-Drug Maker Novo Nordisk Soars To Record On A $2.7 Billion Deal

Novo Nordisk stock popped Wednesday after the drugmaker inked a $2.7 billion deal that bolsters its diabetes and obesity treatments.

Investors Business Daily

Novo Hits Another Record High As WHO Considers A Key Move In Obesity

The World Health Organization will consider adding obesity treatments to its "essential medicines list." The move could help some drug stocks.

StockNews.com

3 High-Quality Stocks to Add to Your Watchlist Now

Despite the bank failures, the Fed will likely keep raising interest rates to bring inflation down. This is expected to keep the stock market under pressure. Amid this backdrop, it could be wise for investors to add high-quality stocks Visa (V), Amgen (AMGN), and Box (BOX) to their watchlist. Keep…

StockNews.com

3 Dow Stocks to Buy More of in March 2023

With the Fed keen on further interest rate hikes this year, the stock market will likely remain under pressure. Amid this backdrop, it could be wise for investors to buy fundamentally strong Dow stocks like Verizon Communications (VZ), Amgen (AMGN), and International Business Machines (IBM). Read more….

Investors Business Daily

Dow Jones Battles Key Support As Indexes Trade Near Session Lows; Sellers Hit Chevron, Salesforce

The Dow Jones held up better than the Nasdaq composite midday Friday, helped by strong showings from Amgen, Merck and Coca-Cola.

Investors Business Daily

AbbVie's Humira: The Downfall Won't Be As 'Draconian' As Initially Expected

AbbVie stock won at least one upgrade Friday after issuing long-awaited guidance for Humira for the first year it faces new competition.

Investors Business Daily

How To Profit From Amgen Stock's Plunge Using Options

Amgen (AMGN) stock has had a difficult few weeks, with the stock dropping from 295 to 240. It is currently the most oversold stock in the Dow Jones Industrial Average. When a quality company has a big drop like this, I like to use a strategy called a diagonal put…

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.